BioSpace News Archive

Business

AVACEN Medical® Welcomes Anthony Shimkin as New Chief Executive Officer

An industry veteran, Shimkin brings more than 25 years of medical and technology commercialization experience to AVACEN.

May 4, 2022
·
2 min read
Business

Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer

Moleculin Biotech, Inc. today announced that the Company has engaged Wolfram C. M. Dempke, MD, PhD, MBA, MRCP as its EU Chief Medical Officer and part-time contractor for its European clinical trials.

May 4, 2022
·
6 min read
Drug Development

Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation

Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation.

May 4, 2022
·
2 min read
Business

Julianne Averill and Kristen Richardson Join Anji Pharma to Ready Company for Next Stage of Growth

Anji Pharma, an emerging global medicines company, announced an expanded leadership team with the appointments of Julianne Averill as Chief Financial Officer and Kristen Richardson as Chief People and Performance Officer.

May 4, 2022
·
4 min read
Drug Development

Imfinzi Plus Chemotherapy Granted Priority Review in the US for Patients With Locally Advanced or Metastatic Biliary Tract Cancer Based on TOPAZ-1 Phase III Trial

AstraZeneca’s supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care chemotherapy, has been accepted and granted Priority Review in the US for patients with locally advanced or metastatic biliary tract cancer (BTC).

May 4, 2022
·
18 min read
Pharm Country

Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis

Synchron today announced the enrollment of the first patient in the US clinical trial, COMMAND, for patient in the US clinical trial, COMMAND, for patients with severe paralysis, at Mount Sinai Hospital in New York.

May 4, 2022
·
3 min read
Biotech Bay

NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents

NeuroPace, Inc today announced that the first patient was treated in the RESPONSE clinical trial, which will evaluate the safety and effectiveness of the RNS ® System in adolescent patients with drug-resistant focal epilepsy.

May 4, 2022
·
5 min read
Business

Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs

Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended March 31, 2022, and provided an update on the Company’s clinical development programs and regulatory and commercial outlook.

May 4, 2022
·
23 min read
Biotech Bay

Pulse Biosciences, Inc. Announces Commencement of Rights Offering - May 04, 2022

Pulse Biosciences, Inc., a novel bioelectric medicine company, announced that it has commenced its previously announced rights offering of up to $15,000,000 of units at the Initial Price.

May 4, 2022
·
5 min read
Drug Development

Amphera’s MesoPher Cell Therapy Demonstrates Favourable Safety and Promising Survival in a Phase II Clinical Trial in Resected Pancreatic Cancer

Amphera B.V. announces positive REACtiVe Phase 2 study safety and efficacy data from the first cohort of 10 patients receiving Amphera’s MesoPher dendritic cell therapy.

May 4, 2022
·
3 min read